Diabetic retinopathy in children and adolescents;La rétinopathie diabétique du sujet jeune: l'Enfant et l'adolescent

Diabetes and Metabolism

Volumn 29, Issue 3, 2003, Pages 300-306

  Mehidi, A Ben ^a,c   Massin, P ^a   Guyot Argenton, C ^b   Erginay, A ^a   Guillausseau, P J ^a   Gaudric, A ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔTEL DIEU   (France)

^c NONE   (France)

Author keywords

Adolescence; Diabetic retinopathy; Growth hormone; IGF 1; Puberty

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BLINDNESS; CHILD; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; HIGH RISK POPULATION; HUMAN; INSULIN TREATMENT; OPHTHALMOSCOPY; PATIENT COMPLIANCE; PATIENT MONITORING; PROGNOSIS; RISK FACTOR;

EID: 0037713239     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1262-3636(07)70041-1     Document Type: Article

References (61)

1. Fairchild JM, Hing SJ, Donaghue KC, et al. Prevalence and risk factors for retinopathy in adolescents with type I diabetes. Med J Aust, 1994, 160, 757-61.
2. Kernell A, Dedorsson I, Johansson B, et al. Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicenter study. Diabetologia, 1997, 40, 307-10.
3. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. Retinopathy in young-onset diabetic patients. Diabetes Care, 1985, 8, 311-5.
4. Kalter-Leibovici O, Leibovici L, Loya N, et al. The development and progression of diabetic retinopathy in type 1 diabetic patients: a cohort-study. Diabet Med, 1997, 14, 858-66.
5. Falck AAK, Käär ML, Laatikainen L. Prevalence and risk factors of retinopathy in children with diabetes. A population-based study on Finnish children. Acta Ophthalmol, 1993, 71, 801-9.
6. Bonney M, Hing SI, Fung AT, Stephens MM, Fairchild IM, Donaghue KG. Development and progression of diabetic retinopathy: adolescents at risk. Diabet Med, 1995, 12, 967-73.
7. Tanner JM. Fetus into man: Physical Growth From Conception to Maturity. Cambridge, Mass: Harvard University Press 1978.
8. Lund-Andersen C, Frost-Larsen K, Starup K. Natural history of diabetic retinopathy in insulin-dependent juvenile diabetics: a longitudinal study. Acta Ophthalmol, 1987, 65, 481-6.
9. Effect of intensive diabetes treatment on the development and progression of long term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Paediatr, 1994, 125, 177-88.
10. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol, 1994, 112, 1217-28.
11. Klein BEK, Moss SE, Klein R. Is menarche associated with diabetic retinopathy? Diabetes Care, 1990, 13, 1034-8.
12. Murphy R, Nanda M, Plotnick L, Enger C, Vitale S, Patz A. The relationship of puberty to diabetic retinopathy. Arch Ophthalmol, 1990, 108, 215.
13. Kostraba JN, Dorman JS, Orchard TJ, et al. Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care, 1989, 12, 686-93.
14. Burger W, Hövener G, Düsterhus R, Hartmann R, Weber B. Prevalence and development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. A longitudinal study. Diabetologia, 1986, 29, 17-22.
15. McNally PG, Raymond NT, Swift PGF, Hearnshaw JR, Burden AC. Does the prepubertal duration of diabetes influence the onset of microvascular complications? Diabet Med, 1993, 10, 906-8.
16. Kokkonen J, Laatikainen L, van Dick-Hoff K, Miettinen R, Tuominen M, Lautala P. Ocular complications in young adults with insulin-dependent diabetes mellitus since childhood. Acta Paediatr, 1994, 83, 273-8.
17. Donaghue KC, Fung ATW, Hing S, Fairchild J, King J, Chan A. The effect of prepubertal diabetes duration on diabetes microvascular complications in early and late adolescence. Diabetes Care, 1997, 20, 77-80.
18. Holl RW, Lang GE, Grabert M, Heinze E, Lang GK, Debatin KM. Diabetic retinopathy in pediatric patients with type 1 diabetes: Effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. J Pediatr, 1998, 132, 790-4.
19. Goldstein DE, Blinder KJ, Ide CH, et al. Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Ophthalmology, 1993, 100, 1125-31.
20. Kein R, Klein BEK, Moss SE, Davis, De Mets OL. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA, 1988, 260, 2864-71.
21. Klein R, Klein BEK, Moss SE, Davis MD, Demets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopthy when age at diagnosis is less than 30 years. Arch Ophthalmol, 1984, 102, 520-6.
22. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in IDDM. N Engl J Med, 1993, 329, 977-86.
23. KROC Collaborative Study Group: Diabetic retinopathy after two years of intensified treatment. JAMA, 1988, 260, 37-41.
24. Danne T, Weber B, Hartmann R, Enders I, Burger W, Hovener G. Long-term glycaemic control has a non-linear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study. Diabetes Care, 1994, 17, 1390-6.
25. Santiago JV. Insulin therapy in the last decade. A pediatric perspective. Diabetes Care, 1993, 16, 143-54.
26. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV. Effect of diabetes and its control on insulin-like growth factors in the young subjects with type 1 diabetes. Diabetes, 1984, 33, 1175-9.
27. Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet, 1997, 350, 1199-204.
28. Acerini L, Williams M, Dunger B. Impact mθtabolique de la puberté sur la prise en charge du diabète de type 1. Diabetes Metab, 2001, 27, 3S19-3S25.
29. Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors. N Engl J Med, 1983, 309, 527-30.
30. Wang Q, Dills DG, Klein R, Klein BEK, Moss SE. Does insulin like growth factor 1 predict incidence and progression of diabetic retinopathy? Diabetes, 1995,44, 161-4.
31. Caird FI, Pirie A, Ramsell TG. Diabetes and the Eye. Boston, Mass: Blackwell Scientific Publications Ed, 1969, 101-9.
32. Haffner SM, Klein R, Dunn IF, Moss SE, Klein BEK. Increased testosin type I diabetic subjects with severe retinopathy. Ophthalmology, 1990, 97, 1270-4.
33. Verougstraete C, Toussaint D, De Schepper I, Haentjens M, Dorchy H. First microangiographic abnormalities in childhood diabetes. Graefe's Arch Clin Exp Ophthalmol, 1991, 229, 24-32.
34. Van Effenterre G, Ameline B, Guiberteau B, Bougnères P. La rétino du sujet jeune. Ophtalmologie, 1993, 7, 37-41.
35. Kohner E, Hamilton AM, Joplin GF, Fraser TR. Florid diabetic retinopathy and its response to treatment by photocoagulation or pituitary ablation. Diabetes, 1976, 25, 104-10.
36. Bandello F, Lanzetta P, Secchi A, et al. Florid diabetic retinopathy: clinical, genetic, metabolic evaluation of 21 patients. Ann Ophthalmol Clin Ocul, 1990, 116, 1285-90.
37. Favard C, Guyot-Argenton C, Assouline M. Full panretinal photocoagulation and early vitrectomy improve prognosis of florid diabetic retinopathy. Ophthalmology, 1996, 103, 561-74.
38. Polkinghorne PJ, Uliss AL, Hamilton AMP. Macular edema and retinal neovascularization in juvenile diabetics. Int Ophthalmol, 1992, 16, 133-7.
39. Lattanzio R, Brancato R, Bandello FM, Azzolini C, Malegori A, Maestranzi G. Florid diabetic retinopathy: a long-term follow-up study. Graefe's Arch Clin Exp Ophthalmol, 2001, 239, 182-7.
40. Bryden KS, Preveler RC, Neil A, Fairburn CG, Mayou RA, Dunger DB. Eating habits, body weight, and insulin misuse: a longitudinal study in teenagers and young adults with type 1 diabetes. Diabetes Care, 1999, 22, 1956-60.
41. Friedman S, Vila G, Timsit J, Boitard C, Mouren-Simeoni MC. Eating disorders and metabolic balance in a population of young adults with insulin-dependent diabetes. Ann Med Psychol, 1995, 153, 282-5.
42. Engsrrom I, Kroon M, Arvidsson CG, Segnestam K, Aman J. Eating disorders in adolescent girls with insulin dependent diabetes mellitus: a population based case-control study. Acta Paediatr, 1999, 88, 175-80.
43. Rydall AC, Rodin GM, Olmsted MP, Devenyi RG, Daneman D. Disordered eating behavior and microvscular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med, 1997, 336, 1849-54.
44. The Diabetic Retinopathy Vitrectomy Study research study group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of randomized trial: Diabetic Retinopathy Vitrectomy Study report 5. Arch Ophthalmol, 1990, 108, 958-64.
45. Tubiana-Rufi N. Pour une prise en charge interdisciplinaire de l'adolescent diabétique « Entre deux équilibres ». Diabetes Metab, 2001, 27, 3S26-3S30.
46. Guitard-Munich CH. L'adolescent et le diabète. Diabetes Metab, 2001, 27, 3S31-3S34.
47. Crosnier H, Tubiana-Rufi N. Modalités du passage des adolescents diabétiques de la pédiatrie aux structures pour adultes dans la région Paris-Ile-de-France: un appel au travail collaboratif pour améliorer la qualité des soins. Arch Pediatr, 1998, 5, 1327-32.
48. American Academy of Pediatrics. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics, 1998, 101, 313-4.
49. Diabetic Retinopathy. American Diabetes Association. Diabetes Care, 1999, 22, S70-S73.
50. American College of Physicians, American Diabetes Association, and American Academy of Ophthalmology. Screening guidelines for diabetic retinopathy. Ophthalmology, 1992, 10, 1626-8.
51. American College of Physicians, American Diabetes Association, and American Academy of Ophthalmology. Screening guidelines for diabetic retinopathy. Diabetes Care, 1995, 18, 21-3.
52. Massin P, Angioi-Duprez K, Bacin F, et al. Recommandations de l'Al-fédiam pour le dépistage et la surveillance de la rétinopathie diabéti que. Diabetes Metab, 1996, 22, 203-9.
53. Retinopathy Working Party. A protocol for screening for diabetic retinopathy in Europe. Diabet Med, 1991, 8, 263-7.
54. Kristinsson JK, Gudmundsson JR, Stefansson E, Jonasson F, Gislason I, Thorsson A. Screening for diabetic retinopahy. Initiation and frequency. Acta Ophthalmol Scand, 1995, 73, 525-8.
55. Massin P, Erginay A, Ben Mehidi A, et al. Evaluation of a new non mydriatic digital camera for detection of diabetic retinopathy. Diabet Med, sous presse.
56. Massin P, Marre M. Place de la photographie du fond d'ceil pour le dépistage de la rétinopathie diabétique. Diabetes Metab, 2002, 28, 151-5.
57. The Diabetes Control and Complications Trial Research group. Color photography versus fluorescein angiography in the detection of diabetic retinopathy in The Diabetes Control and Complications Trial. Arch Ophthalmol, 1987, 105, 1344-51.
58. Tubiana-Rufi N, Du Pasquier-Fediaevsky L. Le concept d'adhésion au traitement du diabète revisité. Diabetes Metab, 1999, 25, 172-6.
59. Reach G. Application de la théorie causale de l'action l'analyse de la non-observance thérapeutique. Presse Med, 2000, 29, 1939-46.
60. Grey M, Boland EA, Yu C, Sullivan-Bolyai S, Tamborlane WV. Personal and family factors associated with quality of life in adolescents with diabetes. Diabetes Care, 1998, 21, 909-14.
61. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality-of-live outcomes in the Diabetes Control and Complications Trial. Diabetes Care, 1996, 19, 195-203.